Univ. Prof. Mag. Dr. med. Markus Mitterhauser
nuclear medicine, radiopharmaceutical chemistry, radiopharmacy, imaging biomarkers
nuclear medicine, radiopharmaceutical chemistry, radiopharmacy, imaging biomarkers
Overview
Country, City
Austria, Vienna
Health facility
Dobling Private Hospital Vienna
Medical unit
Theranostics center
About the doctor
Skills & Expertise
pet
cancer
prostate cancer
prostate
brain
tomography
positron emission tomography
serotonin1a receptor
castrationresistant prostate cancer
depression
serotonin
hormone
bone
tumor
serotonin transporter
dopamine
psma
metabolism
hormone receptor
radioligand
radiopharmacy
11cmethionine
nuclear medicine
melaninconcentrating hormone
norepinephrine transporter
5ht1a
petmri
5ht1a receptor
prostatespecific membrane antigen
inhibitor therapy
metastases
electroconvulsive therapy
lymph node
inflammatory activity
monoamine oxidase
radionuclide therapy
immune checkpoint inhibitor
androgen receptor
radiopharmaceutical chemistry
radioligand therapy
colorectal cancer
d23 receptor
pancreatic 11cmethionine
dna methylation
node metastases
brain imaging
prefrontal cortex
tumor cell
68gagapsma pet
liquid biopsies
Gallery
Medical University of Vienna - Division of Nuclear Medicine
Medical Imaging Cluster - Preclinical Imaging (PI)
Resume
CV (Curriculum Vitae)
Education
- 1989-1996 Studied pharmacy at the University of Vienna
- 1993 Diploma thesis at the Karolinska Institute in Stockholm
- 1993 Researcher at the Turku Positron Emission Tomography Centre
- 1994-1995 Research stays at the Chinese University of Hong Kong
- 1996 Research stay at the Service Hospitalier Frederic Joliot
- 1997-1998 Training at the Saint Nepomuk Pharmacy
- 1998 Obtaining a license for medical practice
- 2000 Postgraduate course in radiopharmaceutical chemistry and radiopharmacy at Swiss Federal Institute of Technology Zurich
- 2003 Receiving dr. rer. nat. degree at the University of Vienna, then the Faculty of Formal and Natural Sciences
- 2006 Licensed to practice as a hospital pharmacist
- 2014-2015 Visiting Professor for radiopharmacy and experimental nuclear medicine at the Faculty of Life Sciences of the University of Vienna, Department of pharmaceutical technology
- 2016 Habilitation for radiopharmacy at the Medical University of Vienna
- 2019 Visiting Professor for Radiopharmacy and Experimental Nuclear Medicine at the Faculty of Life
- 2022 Professorship for applied diagnostics, Faculty of Chemistry at the University of Vienna
Experience
- 1998 Head of the Department of isotope pharmacy at the Vienna General Hospital
- 1999 Head of Department of experimental nuclear medicine at the Vienna General Hospital
- 2016 Founder and Director of the Ludwig Boltzmann Institute Applied Diagnostics
- Department of nuclear medicine at the Theranosticum
Languages
English
German
Publications
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.
26 March, 2024
Radiobiological Assessment of Targeted Radionuclide Therapy with [177Lu]Lu-PSMA-I&T in 2D vs. 3D Cell Culture Models.
30 November, 2023
Quality Assurance Investigations and Impurity Characterization during Upscaling of [177Lu]Lu-PSMAI&T.
21 November, 2023
Location
Heiligenstädter Str., 55, 1190 Vienna, Austria
FAQ
Where does the doctor practice?
What is the specialization of Univ. Prof. Mag. Dr. med. Markus Mitterhauser?
The primary specialization of the doctor is nuclear medicine, radiopharmaceutical chemistry, radiopharmacy, imaging biomarkers.
What is the experience of the specialist?
Univ. Prof. Mag. Dr. med. Markus Mitterhauser has been practicing for more than 28 years.
Univ. Prof. Mag. Dr. med. Markus Mitterhauser
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Univ. Prof. Mag. Dr. med. Markus Mitterhauser